Clinical and Experimental Therapeutics (MS)

A Master of Science (MS) in Clinical Experimental and Therapeutics (CXPT) will be granted on the basis of completion of 28 total units. Students, choosing to complete a Master thesis, can earn at least 24 units through formal course work and complete 4 units from work on a thesis, based on the results of an original investigation. There is a non-thesis option, which entails completing all 28 units from formal course work. Students on the non-thesis track may choose to perform an independent study resulting in a comprehensive review paper on the topic selected in agreement with their adviser. Students should choose either thesis or non-thesis option by the end of the first year of study and prior to the beginning of the second year.

The core course work includes the following recommended courses: CXPT 609  (4 units), CXPT 610  (4 units), CXPT CXPT 664  (3 units; for non-clinically trained students) and one course chosen between PM 501  (4 units) and CXPT 501  (4 units). The remaining elective units will be completed from courses offered within the Alfred Mann School of Pharmacy and Pharmaceutical Sciences or in related disciplines outside the department, approved by the CXPT Program Director. Students, choosing the master’s thesis option, should register for CXPT 594a  (2 units) and CXPT 594b  (2 units) in the second year of the program. For students choosing the independent project on the non-thesis track, CXPT 590  (at least 2 units) can be used. At least 75 percent of the 28 units must be at 500 level or above. One course with maximum of 4 units at the 400 level may be applied toward the degree.